Incidence of apoptosis and metallothionein expression in renal cell carcinoma

British Journal of Urology

Volumn 81, Issue 1, 1998, Pages 9-13

  Zhang, X H ^a   Takenaka, I ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Immunohistochemistry; Metallothionein; Renal cell carcinoma; TUNEL

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; FORMALDEHYDE; METALLOTHIONEIN; PARAFFIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL MEMBRANE; CELL NUCLEUS; CELL TYPE; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOLOGICAL MARKERS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; METALLOTHIONEIN; MIDDLE AGED;

EID: 0031820297     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00506.x     Document Type: Article

References (27)

1. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991: 65: 1097-8
2. Gavrieli Y. Sherrrmn Y. Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992: 119: 439-501
3. Aihara M. Troung CD. Dunn JK. Wheeler TM, Scardino PT. Thompson TC. Frequency of apoptotic bodies positively correlates with Gleason grade in prostate. Hum Pnthot 1994: 25: 797-801
4. Gattney EF. The extent of apoptosis in different types of high grade prostatic carcinoma. Histopathology 1994: 25: 269-73
5. King E. Matteson ). Jacobs SC. Kyprianou N. incidence of apoptosis. cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J LJrol 1996; 155: 316-20
6. Saegusa M. Takano Y, Wakabayashi T, Okayasu I. Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation. Jpii J Cancer Res 1995: 86: 743-8
7. Margoshes M. Vallée BL. A cadmium protein from equine kidney cortex. J Ain Cliem Soc 1957: 799: 4813-4
8. Hamer DH. Metallothionein. Aim Rev Biochem 1986: 55: 913-51
9. Cherian MG. Huang PC. Klaassen CD. Liu YP. Longfellow DG. Waalkes MP. National cancer institue workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res 1993: 53: 922-5
10. Cherian MG. Hovvell SB. Imura N et al. Contemporary issues in toxicology: role of metallothionein in carcinogenesis. Toxicol Appl Pharnmcol 1994: 110: 327-35
11. 1 Presno M. Wu W. Rodriguez JM. Nadji M. Localization of metallothionein in breast carcinomas. An iinmunohistochemical study. Virchows Arch IA J 1993: 425: 215-9
12. Schmid KW. Lllis 10. Gee JMVV et al. Presence and possible significance of immunohistochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch [A J 1993: 422: 153-9
13. 3 Zhang XH. Li J. Sakamoto H. Takenaka 1. [mmunohistochemical localization of metallothionein in human prostate cancer. J Lirai 1996: 156: 1679-81
14. Hamada T. Sasaguri 'I'. Tanimolo A et al. Apoptosis of human kidney 29 3 cells is promoted by polymerized cadmium-metallothionein. Biochem Biophys Res Commun 1996: 219: 829-34
15. 5 Trubiani (). Antonucci A. Palka G. Primio RD. Programmed cell death of peripheral myeloid precursor cells in down patients: effect of zinc therapy. L'Vfrn.s(rnr( PnffioJ 1996: 20: 457-62
16. Thoenes W. Storkel S. Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas. carcinomas). Ri(M R Prncf 1986: 181: 125-43
17. UICC. TNM Classicfication of Malignant Tumorx. 4th edn. Springer-Verlag. 1987 IS Japanese llrological Association. The Japanese Society of Pathology & Japan Radiological Society. General rules for clinical and pathological studies on renal cell carcinoma. 2nd edn. Tokyo: Kinbara press. 1992
18. Ishida M. Gomyo Y. Tatebe S. Ohfuji S. Ito H. Apoptosis in human gastric mucosa. chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transfcrase-mediated dLlTP-biotin nick end labeling. Kirr/imv.s Arcfi 1996:428: 229-35
19. Tatebe S. Ishida M. Kasagi N. Tsujitani S. Kaibara N. Itu H. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal deoxynucleotidyl transferase-mediated dUTPbiotin nick end labeling. Jnf J Omtcr 1996; 65: 173-7
20. Leoncini L. Delvecchino MT. Megha T et al. Correlation between apoptosis and proliferative indies in malignant non-Hodgkin's lymphomas. Ain J PoffinJ 1993: 142: 755-63
21. Lippon PK. Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J PofhoJ 1994: 173: 333-9
22. Basu A. Lazo JS. Supression of Oexamethasone-induccd metallothioncin expression and cis-diamminedichloroplatinum HI) resistance by v-mos. Cmir Kcs 1991: 51: 893-6
23. Tohyama C. Suzuki JS. Hemelread J. Xishimura N. Mshimura H. Induction of metallothionein and its localization in the nucleus of rat hepatocyles after partial hcpatcctomy. Hf-jwfoAw; 1993: 18: 1193-201
24. Majno U. Joris I. Apoptosis. oncosis. and necrosis: an overview of cell death. Am J P;W 1995: 146: 3-15
25. Zhang XH. Jin L. Takenaka I. Localization of zinc and metallothionein in the rat bladder epithelium during carcinogenesis induced by N-butyl-M-(4-hydroxybulyl) nitrosamine. UmJ Rex 1996: 24: 279-S3
26. Barbieri D. Troiano L. (Irassilli E et al A Inhibition of apoptosis by zinc: a reappraisal. JMxVicm HiojVns Kcx Owmmm 1992: 187: 1256-61
27. Hamada T. Nakano S. Iwai S. Tanimoto A. Ariyoshi K. Koide O. Pathological study on beagles after long-term oral administration of cadmium. Toxicol MifmJ 1991: 19: 138-47